BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24534211)

  • 21. Improvement of left ventricular function after successful radiofrequency catheter ablation in persistent atrial fibrillation with preserved left ventricular ejection fraction: a comprehensive echocardiographic assessment using two-dimensional speckle tracking analysis.
    Nagai T; Arakawa J; Hamabe A; Tabata H
    J Echocardiogr; 2019 Jun; 17(2):95-103. PubMed ID: 30276623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation.
    Henningsen KM; Nilsson B; Bruunsgaard H; Chen X; Pedersen BK; Svendsen JH
    Scand Cardiovasc J; 2009; 43(5):285-91. PubMed ID: 19117239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-Procedural Serum Atrial Natriuretic Peptide Levels Predict Left Atrial Reverse Remodeling After Catheter Ablation in Patients With Atrial Fibrillation.
    Nakanishi K; Fukuda S; Yamashita H; Kosaka M; Shirai N; Tanaka A; Yoshikawa J; Shimada K
    JACC Clin Electrophysiol; 2016 Apr; 2(2):151-158. PubMed ID: 29766864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance and levels of blood brain natriuretic peptides in patients with persistent atrial fibrillation before and after catheter ablation.
    Xing SY; Wang HL; Dong PS; Lai LH; Zhu JH; Zhao JF; Shang XY
    Genet Mol Res; 2015 Jun; 14(2):6953-9. PubMed ID: 26125903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of repeated radiofrequency catheter ablation on left atrial function for the treatment of atrial fibrillation.
    Montserrat S; Sitges M; Calvo N; Silva E; Tamborero D; Vidal B; Berruezo A; Bernado C; Mont L; Brugada J
    Am J Cardiol; 2011 Dec; 108(12):1741-6. PubMed ID: 21906703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of radiofrequency catheter ablation on myocardial performance index and plasma NT-Pro-BNP levels in patients with Wolff-Parkinson-White syndrome.
    Cakmak N; Sayar N; Cakmak M; Akyol A; Oguz E; Eksik A; Alper AT; Hasdemir H; Yilmaz H; Erdinler I
    Echocardiography; 2008 Aug; 25(7):692-8. PubMed ID: 18422672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of iatrogenic myocardial injury on coronary microvascular function in patients undergoing radiofrequency catheter ablation of atrial fibrillation.
    Lim HE; Choi CU; Na JO; Choi JI; Kim SH; Kim JW; Kim EJ; Han SW; Park SW; Rha SW; Park CG; Seo HS; Oh DJ; Hwang C; Kim YH
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):318-26. PubMed ID: 23476035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent effect of atrial fibrillation on natriuretic peptide release.
    Sramko M; Wichterle D; Melenovsky V; Franekova J; Clemens M; Fukunaga M; Kautzner J
    Clin Res Cardiol; 2019 Feb; 108(2):142-149. PubMed ID: 30051184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Gaita F; Di Donna P; Olivotto I; Scaglione M; Ferrero I; Montefusco A; Caponi D; Conte MR; Nistri S; Cecchi F
    Am J Cardiol; 2007 Jun; 99(11):1575-81. PubMed ID: 17531584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation.
    Carballo D; Noble S; Carballo S; Stirnemann J; Muller H; Burri H; Vuilleumier N; Talajic M; Tardif JC; Keller PF; Mach F; Shah D
    J Int Med Res; 2018 Dec; 46(12):5183-5194. PubMed ID: 30178684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal energy requirement for external cardioversion and catheter ablation for long-standing persistent atrial fibrillation.
    Kim IS; Kim TH; Yang PS; Uhm JS; Joung B; Lee MH; Pak HN
    J Cardiol; 2017 Jan; 69(1):162-168. PubMed ID: 26987790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impact of pre-procedural plasma brain natriuretic peptide level on atrial fibrillation recurrence post radiofrequency catheter ablation].
    Jin YY; Zhang XY; Zhu XL; Ma CS; Long DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jan; 40(1):39-42. PubMed ID: 22490632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
    Yamabe H; Kaikita K; Matsumura T; Iwasa A; Koyama J; Uemura T; Morikami Y; Tsunoda R; Morihisa K; Fujimoto K; Kajiwara I; Matsui K; Tsujita K; Ogawa H
    J Cardiol; 2018 Feb; 71(2):129-134. PubMed ID: 28886992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of total atrial conduction time estimated with tissue Doppler imaging to predict the recurrence of atrial fibrillation after radiofrequency catheter ablation.
    den Uijl DW; Gawrysiak M; Tops LF; Trines SA; Zeppenfeld K; Schalij MJ; Bax JJ; Delgado V
    Europace; 2011 Nov; 13(11):1533-40. PubMed ID: 21712264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationship between high-sensitivity C-reactive protein (hsCRP) levels and atrial fibrillation early recurrence after paroxysmal atrial fibrillation radiofrequency catheter ablation].
    Zhao YX; Shan ZL; Guo HY; Lin K; Guo JP; Wang YT
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jun; 33(6):526-530. PubMed ID: 29931902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation.
    Shimano M; Inden Y; Tsuji Y; Kamiya H; Uchikawa T; Shibata R; Murohara T
    Europace; 2008 Aug; 10(8):961-6. PubMed ID: 18550508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling.
    Pump A; Di Biase L; Price J; Mohanty P; Bai R; Santangeli P; Mohanty S; Trivedi C; Yan RX; Horton R; Sanchez JE; Zagrodzky J; Bailey S; Gallinghouse GJ; Burkhardt JD; Natale A
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1224-31. PubMed ID: 24020717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-shock sinus node recovery time is an independent predictor of recurrence after catheter ablation of longstanding persistent atrial fibrillation.
    Park J; Shim J; Uhm JS; Joung B; Lee MH; Pak HN
    Int J Cardiol; 2013 Oct; 168(3):1937-42. PubMed ID: 23380697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.